ATRA投与中に麻痺性イレウスを来した急性前骨髄球性白血病

書誌事項

タイトル別名
  • Paralytic ileus during treatment of acute promyelocytic leukemia with all-<i>trans</i> retinoic acid
  • ATRA トウヨ チュウ ニ マヒセイ イレウス オ キタシタ キュウセイ ゼン コツズイキュウセイ ハッケツビョウ
公開日
2000
資源種別
journal article
DOI
  • 10.11406/rinketsu.41.687
公開者
一般社団法人 日本血液学会

この論文をさがす

説明

A 54-year-old man was referred to our hospital because of petechiae and pancytopenia. Bone marrow aspiration showed a normocellular marrow with 92.4% promyelocytes. PML/RARα mRNA was detected by reverse transcription polymerase chain reaction. On the basis of the above data, a diagnosis of acute promyelocytic leukemia (APL) was made, and treatment with all-trans retinoic acid (ATRA) at a dose of 60 mg/day was begun. Fourteen days after the start of treatment, the patient developed paralytic ileus, accompanied by hyperleukocytosis, high fever, renal dysfunction and elevation of the serum FDP level. There was no evidence of infection. At this time, retinoic acid syndrome was suspected, and therefore steroid pulse therapy was started, which led to an improvement of the symptoms within four days. This case suggests that ATRA may have an adverse effect on the small intestine, causing paralytic ileus.

収録刊行物

  • 臨床血液

    臨床血液 41 (8), 687-689, 2000

    一般社団法人 日本血液学会

参考文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ